Souhaitez-vous accéder aux communiqués récents ?

CHICAGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure and improving care for...

COLUMBIA, Md., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Tenable®, the Exposure Management company, today released its annual 2022 Threat Landscape Report, which validates the persistent threat posed by...

LONDON, England, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today marks the launch of the second edition of the Safety Perceptions Index (SPI), a collaboration between Lloyd's Register Foundation, a global...

NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- For his contributions to the field of regeneration, Alejandro Sánchez Alvarado receives the Vilcek Prize in Biomedical Science. The Vilcek Prize in...

Washington, D.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- New survey results highlight American opinions on strategies to mitigate climate change and the best approaches when it comes to fuels and...

STEVENAGE, United Kingdom, Feb. 22, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has been...

MILAN, Italy, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Olon Group and the Politecnico di Milano, Department of Chemistry, Materials and Chemical Engineering “Giulio Natta,” jointly announce an innovative...

Bergen, Norway, 15 February 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane immunotherapy, announces...

NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Rom-coms, Hallmark movies and even Valentine's cards may need a rewrite: Most single people say they don't need a mate for their life story to have a...

Paris, February 13th, 2023 – Ipsos is pleased to announce the acquisition of Xperiti, a start-up specializing in Business-to-Business (B2B) research, with operations across the US, Israel and the...